Dexcom Ventures
Investment Details
Investor Type
Corporate VC
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Growth
Geographical Focus
United States, United Kingdom, Germany, Hong Kong, Australia, Ireland
Industries Focus
- Technology
- Healthcare
- Artificial Intelligence
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Cybersecurity
- Biotechnology
- Data Analytics
- Remote Patient Monitoring
- Population Health
- Metabolic Monitoring
- Diabetes Care
- Wearable Technology
Investor Details Founded: 2021
Dexcom Ventures is the corporate venture capital arm of Dexcom, Inc., a leader in continuous glucose monitoring (CGM) systems for diabetes management. The venture arm seeks to identify and invest in transformational technologies that complement Dexcom's core business and advance the development of adjacent technologies for the future. Their mission is to drive the next wave of health innovations through a world-class venture capital platform.
The investment strategy of Dexcom Ventures focuses on identifying and investing in promising transformational technology platforms adjacent to or related to Dexcom's core strategy. This includes areas such as sensing technology, data analytics, remote patient monitoring, and population health. The goal is to support independent initiatives in glucose sensing technologies and adjacent fields of metabolic monitoring, thereby broadening Dexcom's commitment to advancing better outcomes in healthcare.
Dexcom Ventures leverages over 20 years of combined experience that helped shape Dexcom into a multibillion-dollar company rooted in transformational technology. The leadership team aims to build a portfolio of value-added strategic investments by leveraging access to Dexcom's unique industry expertise and technology leadership. They strive to be value-add strategic investors, supporting portfolio companies as they pioneer markets and drive innovation in healthcare.
Requirements
- Innovative technologies in healthcare
- Alignment with Dexcom's core business
- Potential for significant impact in diabetes care and related fields
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- MedCrypt
- Nutromics
- Epitel
- Signos
- BioIntelliSense
- Beta Bionics
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$14.95
-
$19.95
-
$39.95
-
$299.00
Claim this Investor
Are you an official representative of Dexcom Ventures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim